These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 10799675

  • 1. MRZ 2/579, a novel uncompetitive N-methyl-D-aspartate antagonist, reduces infarct volume and brain swelling and improves neurological deficit after focal cerebral ischemia in rats.
    Liu Y, Belayev L, Zhao W, Busto R, Ginsberg MD.
    Brain Res; 2000 Apr 17; 862(1-2):111-9. PubMed ID: 10799675
    [Abstract] [Full Text] [Related]

  • 2. Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats.
    Belayev L, Khoutorova L, Deisher TA, Belayev A, Busto R, Zhang Y, Zhao W, Ginsberg MD.
    Stroke; 2003 Mar 17; 34(3):758-63. PubMed ID: 12624304
    [Abstract] [Full Text] [Related]

  • 3. HU-211, a novel noncompetitive N-methyl-D-aspartate antagonist, improves neurological deficit and reduces infarct volume after reversible focal cerebral ischemia in the rat.
    Belayev L, Busto R, Zhao W, Ginsberg MD.
    Stroke; 1995 Dec 17; 26(12):2313-9; discussion 2319-20. PubMed ID: 7491657
    [Abstract] [Full Text] [Related]

  • 4. Neuroprotective effect of treatment with human albumin in permanent focal cerebral ischemia: histopathology and cortical perfusion studies.
    Liu Y, Belayev L, Zhao W, Busto R, Belayev A, Ginsberg MD.
    Eur J Pharmacol; 2001 Oct 05; 428(2):193-201. PubMed ID: 11675036
    [Abstract] [Full Text] [Related]

  • 5. Neuroprotection by LY341122, a novel inhibitor of lipid peroxidation, against focal ischemic brain damage in rats.
    Huh PW, Belayev L, Zhao W, Clemens JA, Panetta JA, Busto R, Ginsberg MD.
    Eur J Pharmacol; 2000 Feb 11; 389(1):79-88. PubMed ID: 10686299
    [Abstract] [Full Text] [Related]

  • 6. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window.
    Belayev L, Liu Y, Zhao W, Busto R, Ginsberg MD.
    Stroke; 2001 Feb 11; 32(2):553-60. PubMed ID: 11157196
    [Abstract] [Full Text] [Related]

  • 7. Caffeinol confers cortical but not subcortical neuroprotection after transient focal cerebral ischemia in rats.
    Belayev L, Khoutorova L, Zhang Y, Belayev A, Zhao W, Busto R, Ginsberg MD.
    Brain Res; 2004 May 22; 1008(2):278-83. PubMed ID: 15145766
    [Abstract] [Full Text] [Related]

  • 8. A glycine site antagonist, ZD9379, reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion.
    Tatlisumak T, Takano K, Meiler MR, Fisher M.
    Stroke; 1998 Jan 22; 29(1):190-5. PubMed ID: 9445350
    [Abstract] [Full Text] [Related]

  • 9. A glycine site antagonist ZD9379 reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion.
    Tatlisumak T, Takano K, Meiler MR, Fisher M.
    Acta Neurochir Suppl; 2000 Jan 22; 76():331-3. PubMed ID: 11450037
    [Abstract] [Full Text] [Related]

  • 10. LAU-0901, a novel platelet-activating factor antagonist, is highly neuroprotective in cerebral ischemia.
    Belayev L, Khoutorova L, Atkins K, Gordon WC, Alvarez-Builla J, Bazan NG.
    Exp Neurol; 2008 Dec 22; 214(2):253-8. PubMed ID: 18793637
    [Abstract] [Full Text] [Related]

  • 11. Neuroprotective activity of a nanoparticulate formulation of the glycineB site antagonist MRZ 2/576 in transient focal ischaemia in rats.
    Sopala M, Schweizer S, Schäfer N, Nürnberg E, Kreuter J, Seiller E, Danysz W.
    Arzneimittelforschung; 2002 Dec 22; 52(3):168-74. PubMed ID: 11963643
    [Abstract] [Full Text] [Related]

  • 12. The effect of bone morphogenetic protein-7 (BMP-7) on functional recovery, local cerebral glucose utilization and blood flow after transient focal cerebral ischemia in rats.
    Liu Y, Belayev L, Zhao W, Busto R, Saul I, Alonso O, Ginsberg MD.
    Brain Res; 2001 Jun 29; 905(1-2):81-90. PubMed ID: 11423082
    [Abstract] [Full Text] [Related]

  • 13. Administration of a competitive NMDA antagonist MDL-100,453 reduces infarct size after permanent middle cerebral artery occlusion in rat.
    Jiang N, Zhang RL, Baron BM, Chopp M.
    J Neurol Sci; 1996 Jun 29; 138(1-2):36-41. PubMed ID: 8791236
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic time window of neuroprotection by non-competitive AMPA antagonists in transient and permanent focal cerebral ischemia in rats.
    Matucz E, Móricz K, Gigler G, Benedek A, Barkóczy J, Lévay G, Hársing LG, Szénási G.
    Brain Res; 2006 Dec 06; 1123(1):60-7. PubMed ID: 17064671
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage.
    Liu XF, Fawcett JR, Thorne RG, DeFor TA, Frey WH.
    J Neurol Sci; 2001 Jun 15; 187(1-2):91-7. PubMed ID: 11440750
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats.
    Thiyagarajan M, Sharma SS.
    Life Sci; 2004 Jan 09; 74(8):969-85. PubMed ID: 14672754
    [Abstract] [Full Text] [Related]

  • 19. NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat.
    Zhao Z, Cheng M, Maples KR, Ma JY, Buchan AM.
    Brain Res; 2001 Aug 03; 909(1-2):46-50. PubMed ID: 11478919
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.